[Translation] A randomized, double-blind, single-dummy placebo-controlled, multicenter phase Ⅱa clinical trial of Shuganzhi tablets in the treatment of nonalcoholic simple fatty liver disease with liver depression, spleen deficiency, and damp-heat syndrome
初步评价疏肝脂片治疗非酒精性单纯性脂肪肝(肝郁脾虚兼湿热证)的有效性及安全性,探索给药剂量
[Translation] To preliminarily evaluate the efficacy and safety of Shuganzhi tablets in the treatment of non-alcoholic simple fatty liver (liver depression, spleen deficiency and damp-heat syndrome), and explore the dosage